NEUROACTIVE STEROIDS, PHARMACEUTICAL PREPARATION, METHOD OF TREATMENT AND PROPHYLAXIS OF DIFFERENT DISORDERS, METHOD OF SLEEP INDUCTION AND METHOD OF ANESTHESIA INDUCTION WITH THEIR USING, METHOD OF MODULATION OF COMPLEX RECEPTOR GABAA-CHLORIDE IONOPHORE Russian patent published in 2002 - IPC

Abstract RU 2194712 C2

FIELD: organic chemistry, steroids, medicine, pharmacy. SUBSTANCE: invention describes novel neuroactive steroids of androstane and pregnane order of the formula (I) or their physiologically acceptable 3-esters where R means H or lower alkoxy-group; R1 means H, C1-10-alkyl, C2-10-alkenyl, C2-10-alkynyl, halogen-C1-10-alkyl, trihalogen-C1-10-alkyl, hydroxy-C2-10-alkynyl, alkoxy-C1-10- alkyl, optionally substituted phenylalkynyl, hydroxyalkynyldicarboxylic acid hemiester; R2 means H or keto-group; R3 means optionally substituted alkoxy-, alkynylhydroxy-, optionally substituted phenyl- alkynylhydroxy-group, -C(O)-CH2-Y-G, -C(O)-CH2-O-D, -C(O)-CH2-O-E, -C(O)-CH2-Z-G or C(O)- CH2-Y-Z-A where Y means O, S, SO or SO2; Z means C1-10-alkyl; G means pyridyl or optionally substituted phenyl; D means quinoline joined to carbon atom; E means optionally substituted phenyl; A means OH, carboxyl or sulfonate; R4 means H; R5 means H; R6 means H; R7 means H or OH; R8 means H; R9 means H; R10 means H under condition that: when R3 means C1-3-alkoxy-group and R means H then R1 differs from H; when R3 means C1-4-alkoxy-C1-4/ - -alkoxy-group then R1 differ from H or 1-propenyl; when R3 means -C(O)-CH2-Y-G and G means pyridyl joined to carbon atom then R1 differs from H or C1-10-alkyl; or when R3 means C(O)-CH2-Z-G then R1 differs from H. Compounds of the formula (I) are able to effect on brain excitability and relieve stress, insomnia, mood disorders caused by agents exhibiting activity with respect to GRC. EFFECT: improved method of treatment and prophylaxis, valuable medicinal properties. 39 cl, 10 tbl, 1 dwg, 49 ex

Similar patents RU2194712C2

Title Year Author Number
STEROID COMPOUNDS (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OF PATIENTS WITH NERVOUS DISORDERS (VARIANTS) AND METHOD OF ANESTHESIA INDUCTION IN ANIMAL 1995
  • Boldzhehr Majkl B.
  • Gi Kelvin U.
  • Lehn Nensi K.
  • Pehrdi Robert
  • Takhir Khasan
  • Jupehzehnaj Rehjvindra B.
RU2176248C2
NEW STEROID COMPOUNDS SHOWING HIGHER WATER SOLUBILITY AND METABOLISM RESISTANCE, AND METHODS FOR PREPARING THEM 2007
  • Behkstrem Torb'Ern
  • Ragagnin Dzhinna
RU2458065C2
DERIVATIVES OF ANDROSTANE SUBSTITUTED AT 16-POSITION WITH QUATERNARY AMMONIUM GROUP, PHARMACEUTICAL COMPOSITION 1993
  • Zoltan Tuba
  • Sil'Vester E.Vizi
  • Ferents F.Foldes
  • Shandor Makho
RU2124021C1
ANDROSTANES 1995
  • Dehvid L. Berliner
  • Natan V. Adams
  • Kliv L. Dzhennings-Vajt
RU2160740C2
METHOD OF SYNTHESIS OF DISUBSTITUTED 2,3-HYDROXYMETHYLCYCLOBUTANOL 1993
  • Dzhenek Sing
  • Gregori S.Bissachi
  • Richard Kh.Mjuller
RU2118312C1
OLIGOSACCHARIDE-CONTAINING 14-AMINOSTEROIDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT, METHOD OF AMINO-GROUP INCORPORATION 1994
  • Dibajs Pol' Majkl
  • Dzhonson Roland Norman
  • Maf Rendi Stjuart
  • L'Ju Song
  • Portlok Dehvid Ehdvard
RU2153503C2
ANDROSTEN(ANE) (ONE) DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF, METHODS OF PREPARATION THEREOF, AND METHOD OF MEDICAL TREATMENT 1994
  • Behchelor Kennet Uil'Jam
  • Fraj Stiven Vernon
RU2144037C1
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE 1992
  • Glenn Dzh.Gomlej
  • Ehlizabet Stoner
RU2125879C1
16α-BROMO-3β-HYDROXY-5α-ANDROSTANE-17-ONE SEMIHYDRATE, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITIONS, USING COMPOUNDS 2000
  • Alem Klarens Nataniehl
  • Frinke Dzhejms Martin
  • De Karval'O Luis Daniehl' Dos Ankhos
  • Khehggi Vil'Jam
  • Prendergast Patrik T.
  • Riding Kristofer L.
  • Tadikonda Krupakar Pol
  • Vernon Rassehl' Nehjl
RU2295534C2
INHIBITORS OF TESTOSTERONE 5α-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TESTOSTERONE 5α-REDUCTASE ACTIVITY 1993
  • Fernand Labri
  • Iv Meran
  • Shankar M.Singkh
RU2141967C1

RU 2 194 712 C2

Authors

Lehn Nensi K.

Fik Dehvid B.

Khogenkehmr Derk Dzh.

Jupehzehnaj Rehjvindra B.

Dates

2002-12-20Published

1996-06-06Filed